Market Place
Sourcing Support
DemeRx Receives MHRA Approval for DMX-1002 (Ibogaine) to Commence Phase 1/2a
10 Mar 2021 //
PRNEWSWIRE
MHRA green light for DemeRx’s opioid use disorder trial
10 Mar 2021 //
PHARMATIMES
DemeRx and Atai get MHRA nod to start trial of ibogaine for opioid use disorder
10 Mar 2021 //
CLINICALTRIALSARENA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.